12012 — MIMEDI (Q3698691)

From EU Knowledge Graph
Revision as of 13:51, 16 May 2022 by Admin (talk | contribs) (‎Removed claim: summary (P836): Innovative medicines (medium) have recently emerged to propose new treatment solutions for patients with therapeutic deadlocks. These media are based on the use of “drug” cells. However, the manufacture of these drugs requires the implementation of complex and therefore costly technologies. MiMédi aims to streamline their manufacturing by providing new technical solutions and optimising all the steps necessary for their production. To do so, M...)
Jump to navigation Jump to search
Project Q3698691 in France
  • 12012 – MIMEDI
Language Label Description Also known as
English
12012 — MIMEDI
Project Q3698691 in France
  • 12012 – MIMEDI

Statements

0 references
0 references
10,211,026.83 Euro
0 references
13,614,711.32 Euro
0 references
75.0 percent
0 references
1 December 2017
0 references
30 November 2021
0 references
Université de Franche-Comté
0 references
0 references

47°14'23.03"N, 6°0'44.14"E
0 references
25030
0 references
Les médicaments innovants (MédI) ont récemment émergé afin de proposer de nouvelles solutions de traitement pour les patients en impasse thérapeutique. Ces MédI sont basés sur l’utilisation de cellules « médicaments ». Or, la fabrication de ces médicaments nécessite de mettre en oeuvre des technologies complexes et donc coûteuses. MiMédi a pour ambition de rationaliser leur fabrication en apportant de nouvelles solutions techniques et en optimisant l’ensemble des étapes nécessaires à leur production. Pour se faire, MiMédi associe des laboratoires de recherche et des industriels francs-comtois aussi bien issus des sciences de l’ingénieur que de l’ingénierie cellulaire. (French)
0 references
Innovative (medium) medicines have recently emerged in order to offer new treatment solutions for patients with therapeutic impasses. These medicinal products are based on the use of “drug” cells. However, the manufacture of these drugs requires the implementation of complex and therefore costly technologies. MiMédi’s ambition is to streamline their manufacturing by providing new technical solutions and optimising all the steps necessary for their production. To do this, MiMédi combines research laboratories and industry from both engineering and cellular engineering. (English)
22 November 2021
0 references
Recentemente sono emersi medicinali innovativi (medii) al fine di offrire nuove soluzioni terapeutiche ai pazienti con impasse terapeutica. Questi medicinali sono basati sull'uso di cellule "farmaci". Tuttavia, la produzione di questi farmaci richiede l'attuazione di tecnologie complesse e quindi costose. L'ambizione di MiMédi è di razionalizzare la loro produzione fornendo nuove soluzioni tecniche e ottimizzando tutte le fasi necessarie per la loro produzione. Per fare questo, MiMédi combina laboratori di ricerca e industria sia di ingegneria che di ingegneria cellulare. (Italian)
12 January 2022
0 references
Device for biological element sorting by acoustophoresis. (English)
Quarroz – FEMTO, Univ-Franche-Comte 2018
0 references

Identifiers

FC0013440
0 references
10341
0 references
4607
0 references